Market Research Report
Global Traumatic Brain Injury Therapeutics Market 2019-2023
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||759934|
|Published||Content info||118 Pages
Delivery time: 1-2 business days
|Global Traumatic Brain Injury Therapeutics Market 2019-2023|
|Published: December 10, 2018||Content info: 118 Pages||
TBI is also known as an intracranial injury. It occurs when an external force causes damage to the brain. The high prevalence of TBI globally is because of the increase in the number of falls road accidents, and other causes. In most of these cases people with TBI need to be hospitalized. The prevalence of TBI among various age groups and eternal causes are important driving factors for the global TBI therapeutics market. The traumatic brain injury therapeutics market growth at a CAGR of close to 5% during the forecast period
The drug development process is a long and expansive process. The number of molecules under development for the treatment of TBI is increasing at a substantial rate because of the rising prevalence of TBI globally.
Most drugs are mostly symptomatic and not curative. The substitutes prove to be more efficient and are preferred among patients. This is expected to pose a challenge to the market.
For the detailed list of factors that will drive and challenge the growth of the traumatic brain injury therapeutics market during the 2019-2023, view our report.
The global traumatic brain injury therapeutics market is extremely fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.